Which of the following indications is NOT associated with Fluconazole?

Which of the following indications is NOT associated with Fluconazole?

• A. Candidal vulvovaginitis
• B. Oropharyngeal candidiasis
• C. Antifungal prophylaxis in neutropenic patients
• D. Cryptococcal meningitis

Answer: (C)

Fluconazole is an antifungal medication that is commonly used for a variety of fungal infections. It is effective in treating candidal vulvovaginitis, which is a vaginal yeast infection caused by Candida species. Additionally, it is used to combat oropharyngeal candidiasis, an oral fungal infection, particularly in immunocompromised patients. Fluconazole is also indicated for the treatment of cryptococcal meningitis, especially in patients with HIV/AIDS, as it helps in managing fungal infections in the central nervous system. In contrast, antifungal prophylaxis in neutropenic patients is not a primary indication for fluconazole. Prophylactic antifungal therapy generally involves the use of broader-spectrum antifungals, such as voriconazole or echinocandins, especially in patients at high risk for invasive fungal infections due to prolonged neutropenia following chemotherapy. Therefore, the indication not associated with fluconazole reflects its typical use profile within the context of antifungal treatment, supporting the rationale for the answer choice.

Fluconazole is an antifungal medication that is commonly used for a variety of fungal infections. It is effective in treating candidal vulvovaginitis, which is a vaginal yeast infection caused by Candida species. Additionally, it is used to combat oropharyngeal candidiasis, an oral fungal infection, particularly in immunocompromised patients. Fluconazole is also indicated for the treatment of cryptococcal meningitis, especially in patients with HIV/AIDS, as it helps in managing fungal infections in the central nervous system.

In contrast, antifungal prophylaxis in neutropenic patients is not a primary indication for fluconazole. Prophylactic antifungal therapy generally involves the use of broader-spectrum antifungals, such as voriconazole or echinocandins, especially in patients at high risk for invasive fungal infections due to prolonged neutropenia following chemotherapy. Therefore, the indication not associated with fluconazole reflects its typical use profile within the context of antifungal treatment, supporting the rationale for the answer choice.